4.6 Article

Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C]UCB-J and [18F]FDG PET Study

Journal

MOVEMENT DISORDERS
Volume -, Issue -, Pages -

Publisher

WILEY
DOI: 10.1002/mds.29375

Keywords

Parkinson's disease; dementia; [F-18]FDG PET; [C-11]UCB-J; synapse

Ask authors/readers for more resources

This study investigated the relationship between in vivo glucose uptake and the magnitude of synaptic density in Lewy body patients using PET technology. The results showed regional differences in synaptic density and glucose consumption in patients with and without dementia, as well as clear differences in cortical regions between demented patients and controls. Importantly, the magnitude of reduced glucose uptake exceeded the magnitude of reduced cortical synaptic density, suggesting that progressive hypometabolism in Lewy body disorders cannot be fully explained by generalized synaptic degeneration.
BackgroundPatients with Lewy body diseases exhibit variable degrees of cortical and subcortical hypometabolism. However, the underlying causes behind this progressive hypometabolism remain unresolved. Generalized synaptic degeneration may be one key contributor. ObjectiveThe objective of this study was to investigate whether local cortical synaptic loss is proportionally linked to the magnitude of hypometabolism in Lewy body disease. MethodUsing in vivo positron emission tomography (PET) we investigated cerebral glucose metabolism and quantified the density of cerebral synapses, as measured with [F-18]fluorodeoxyglucose ([F-18]FDG) PET and [C-11]UCB-J, respectively. Volumes-of-interest were defined on magnetic resonance T1 scans and regional standard uptake value ratios-1 values were obtained for 14 pre-selected brain regions. Between-group comparisons were conducted at voxel-level. ResultsWe observed regional differences in both synaptic density and cerebral glucose consumption in our cohorts of non-demented and demented patients with Parkinson's disease or dementia with Lewy bodies compared to healthy subjects. Additionally, voxel-wise comparisons showed a clear difference in cortical regions between demented patients and controls for both tracers. Importantly, our findings strongly suggested that the magnitude of reduced glucose uptake exceeded the magnitude of reduced cortical synaptic density. ConclusionHere, we investigated the relationship between in vivo glucose uptake and the magnitude of synaptic density as measured using [F-18]FDG PET and [C-11]UCB-J PET in Lewy body patients. The magnitude of reduced [F-18]FDG uptake was greater than the corresponding decline in [C-11]UCB-J binding. Therefore, the progressive hypometabolism seen in Lewy body disorders cannot be fully explained by generalized synaptic degeneration. (c) 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Prediction of neuropathologic lesions from clinical data

Thanaphong Phongpreecha, Brenna Cholerton, Syed Bhukari, Alan L. L. Chang, Davide De Francesco, Melan Thuraiappah, Dana Godrich, Amalia Perna, Martin G. Becker, Neal G. Ravindra, Camilo Espinosa, Yeasul Kim, Eloise Berson, Samson Mataraso, Sharon J. J. Sha, Edward J. Fox, Kathleen S. Montine, Laura D. Baker, Suzanne Craft, Lon White, Kathleen L. Poston, Gary Beecham, Nima Aghaeepour, Thomas J. Montine

Summary: This study used statistical tools and machine learning to predict 17 neuropathologic lesions based on 381 clinical features of 6518 individuals. The results showed high prediction performance for certain lesions. Some clinical features were strongly associated with multiple neurodegenerative diseases, while others were specific to certain lesions.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Illusory Responses across the Lewy Body Disease Spectrum

Marian Shahid, Ashley Rawls, Veronica Ramirez, Sephira Ryman, Veronica E. Santini, Laurice Yang, Sharon J. Sha, Jacob N. Hall, Thomas J. Montine, Amy Lin, Lu Tian, Victor W. Henderson, Brenna Cholerton, Maya Yutsis, Kathleen L. Poston

Summary: This study aimed to investigate pareidolias in patients across the Lewy body disease spectrum. Illusory responses were studied in 300 participants, and it was found that cognitively impaired LB patients were more likely to endorse illusory responses compared to other groups. The Noise Pareidolia Task can be used to screen for unobtrusive pareidolias in LB patients before the onset of hallucinations and delusions.

ANNALS OF NEUROLOGY (2023)

Article Clinical Neurology

Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's Disease

Sephira G. Ryman, Nicholas Shaff, Andrew Dodd, Stephanie Nitschke, Christopher Wertz, Kayla Julio, Gerson Suarez Cedeno, Amanda Deligtisch, Erik Erhardt, Henry Lin, Andrei Vakhtin, Kathleen L. Poston, Rawan Tarawneh, Sarah Pirio Richardson, Andrew Mayer

Summary: This study aimed to investigate cerebrovascular dysfunction in participants with Parkinson's disease (PD) compared to healthy controls (HC) using functional magnetic resonance imaging (fMRI) and vasodilatory challenges. The results showed that PD participants had reduced and delayed cerebrovascular reactivity, which may be associated with chronic hypoxia, neuroinflammation, and protein aggregation. Cerebrovascular reactivity may serve as an important biomarker and target for future interventions in PD.

MOVEMENT DISORDERS (2023)

Article Neurosciences

Distribution of cholinergic nerve terminals in the aged human brain measured with [18F]FEOBV PET and its correlation with histological data

Niels Okkels, Jacob Horsager, Miguel A. Labrador-Espinosa, Frederik O. Hansen, Katrine B. Andersen, Mie Kristine Just, Tatyana D. Fedorova, Casper Skjaerbaek, Ole L. Munk, Kim V. Hansen, Hanne Gottrup, Allan K. Hansen, Michel J. Grothe, Per Borghammer

Summary: This study used [18F]FEOBV PET tracer to study the cholinergic topography of the healthy human brain. The results showed the highest tracer binding in the striatum, thalamic nuclei, and basal forebrain. The spatial distribution of the tracer correlated well with immunohistochemical and gene expression data.

NEUROIMAGE (2023)

Article Clinical Neurology

Cognitive Impairment in Neurodegenerative Movement Disorders

Carla Abdelnour, Kathleen L. Poston

Summary: Patients with neurodegenerative movement disorders can develop cognitive impairment which is associated with decreased quality of life, higher caregiver burden, and earlier institutionalization. Evaluating cognitive performance in these patients is important for diagnosis, management, prognosis, and support. This review discusses the cognitive impairment profile in different movement disorders and provides neurologists with practical guidance and evaluation tools.

SEMINARS IN NEUROLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Sertraline treatment influences [18F]FE-PE2I PET imaging for Parkinsonism

Thomas E. H. Justesen, Per Borghammer, Joel Aanerud, Peter Hovind, Lisbeth Marner

Summary: The commonly used antidepressant sertraline has been found to interfere with the results of [F-18]FE-PE2I PET, leading to reduced binding in the caudate nucleus. It is recommended to take sertraline treatment into account when performing [F-18]FE-PE2I PET, especially in patients with apparent globally reduced PE2I binding. Consideration should be given to pausing sertraline treatment, particularly for doses above 50 mg/day.

EJNMMI RESEARCH (2023)

Article Clinical Neurology

The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study

Charlotte B. B. Stewart, David Ledingham, Victoria K. K. Foster, Kirstie N. N. Anderson, Sahana Sathyanarayana, Debra Galley, Nicola Pavese, Jacopo Pasquini

Summary: Autonomic dysfunction is common in early Parkinson's Disease and tends to worsen over time. Many patients experience multiple autonomic symptoms, including gastrointestinal, cardiovascular, and urinary dysfunction. The severity of autonomic dysfunction is associated with the severity of olfactory dysfunction and motor impairment.

FRONTIERS IN NEUROLOGY (2023)

Article Clinical Neurology

Quantitative estimate of cognitive resilience and its medical and genetic associations

Thanaphong Phongpreecha, Dana Godrich, Eloise Berson, Camilo Espinosa, Yeasul Kim, Brenna Cholerton, Alan L. Chang, Samson Mataraso, Syed A. Bukhari, Amalia Perna, Koya Yakabi, Kathleen S. Montine, Kathleen L. Poston, Elizabeth Mormino, Lon White, Gary Beecham, Nima Aghaeepour, Thomas J. Montine

Summary: The study proposes a framework for defining cognitive resilience (CR) as a continuous variable for each neuropsychological test, aiming to address discrepancies and shortcomings of the current CR definition. The framework clarifies the relationship between CR and closely related terms and provides insights into the underlying mechanisms of CR.

ALZHEIMERS RESEARCH & THERAPY (2023)

Article Clinical Neurology

The Clinical Profile of Tremor in Parkinson's Disease

Jacopo Pasquini, Gunther Deuschl, Alessandro Pecori, Stefano Salvadori, Roberto Ceravolo, Nicola Pavese

Summary: This study conducted a comprehensive longitudinal analysis on tremor in de-novo PD patients, revealing that tremor severity increases over time and the response to medication varies. The findings provide an evidence-based framework for future pathophysiological and interventional studies on PD tremor.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Clinical Neurology

Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C]UCB-J and [18F]FDG PET Study

Katrine B. Andersen, Allan K. Hansen, Anna Christina Schacht, Jacob Horsager, Hanne Gottrup, Henriette Klit, Erik H. Danielsen, Kathleen L. Poston, Nicola Pavese, David J. Brooks, Per Borghammer

Summary: In this study, the relationship between synaptic density and glucose metabolism in Lewy body disease patients was investigated using PET and other techniques. The results showed that the magnitude of reduced glucose uptake exceeded the magnitude of reduced cortical synaptic density.

MOVEMENT DISORDERS (2023)

No Data Available